메뉴 건너뛰기




Volumn 7, Issue 5, 2007, Pages 504-514

Targeting aberrant TGF-β signaling in pre-clinical models of cancer

Author keywords

Antagonists; Cancer; Kinase inhibitors; Knock down strategies; Ligand traps; Pre clinical models; Targeted therapies; TGF pathway

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; A 83 01; ANTINEOPLASTIC AGENT; ANTISENSE OLIGONUCLEOTIDE; AP 11014; AP 12009; CYTOKINE; DENDRITIC CELL VACCINE; GAMMA INTERFERON; GC 1008; HTS 466284; IMMUNOGLOBULIN FC FRAGMENT; LERDELIMUMAB; LIGAND; LY 364947; LY 566578; LY 580276; METELIMUMAB; MONOCLONAL ANTIBODY 1D11; MONOCLONAL ANTIBODY 2G7; NEUTRALIZING ANTIBODY; ONCOLYTIC ADENOVIRUS; SB 505124; SD 093; SD 208; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; TRANSFORMING GROWTH FACTOR BETA2; UNINDEXED DRUG;

EID: 35748960275     PISSN: 18715206     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152007781668689     Document Type: Review
Times cited : (19)

References (134)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.